s6y
Company name or ticker
Search
Greenberg Richard S
4
NEXIEN BIOPHARMA, INC.: Statement of changes in beneficial ownership of securities
Filed
Monday, January 31, 2022
Period
Jan 27, 2022
Accession number
0001214659-22-001420
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header